Norges Bank’s Loxo Oncology, Inc LOXO Stock Holding History

Norges Bank’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-434,018	Closed	-$60.8M	–	2153
2018 Q4	$60.8M	Buy	434,018 +16,225	+4%	+$2.46M	0.02%	634
2018 Q3	$71.4M	Buy	417,793 +94,200	+29%	+$15.8M	0.02%	642
2018 Q2	$56.1M	Buy	323,593 +25,470	+9%	+$3.83M	0.02%	750
2018 Q1	$34.4M	Buy	298,123 +36,578	+14%	+$3.89M	0.01%	1048
2017 Q4	$22M	Buy	261,545 +75,383	+40%	+$6.28M	0.01%	1419
2017 Q3	$17.1M	Buy	+186,162	New	+$14.5M	0.01%	1531

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Norges Bank's LOXO Position: Q1 2019 in Review

Norges Bank sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 434,018 shares — an estimated $60.8M sold.

Norges Bank first reported a position in LOXO in Q3 2017 and held it in 6 quarters. The position peaked at $71.4M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Norges Bank reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Norges Bank sold 434,018 Loxo Oncology, Inc shares in Q1 2019, an estimated $60.8M.
Norges Bank first reported a position in Loxo Oncology, Inc in Q3 2017 and held it in 6 quarters.
Norges Bank's Loxo Oncology, Inc position peaked at $71.4M in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Norges Bank's 13F filing for Q1 2019, filed 9 May 2019.